Impact of an oral anticoagulation self-monitoring and self-management program in patients with mechanical heart valve prosthesis.
Research article published in Journal of comparative effectiveness research (2021)
Abstract
Objective: To analyze impact of implementation of an oral anticoagulation self-monitoring and self-management program among patients with mechanical valve prosthesis. Materials & methods: Observational and retrospective study performed in Hospital Moises Broggi, Barcelona, Spain. The program started on June 2019. The study compared 6-month period before and after the implementation of the program. Results: The study included 44 patients. There was a numerical increase of time in therapeutic range from 53.6 ± 21.3% to 57.1 ± 15.7% (p = 0.30). Proportion of patients with international normalized ratio (INR) >5 significantly decreased from 3.9 to 2.0% (p = 0.04). No significant differences were observed in thromboembolic or bleeding complications. Visits to emergency department decreased from (29.5 to 22.7%; p = 0.41). Conclusion: Oral anticoagulation self-monitoring and self-management program seems an appropriate approach that could provide additional benefits in selected patients with mechanical valve prosthesis.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
To analyze impact of implementation of an oral anticoagulation self-monitoring and self-management program among patients with mechanical valve prosthesis.Observational and retrospective study performed in Hospital Moises Broggi, Barcelona, Spain. The program started on June 2019.
Por qué esto importa para la hirudoterapia
Este estudio observacional retrospectivo analizó el impacto de la implementación de un programa de automonitoreo y automanejo de la anticoagulación oral para pacientes con prótesis valvulares cardíacas mecánicas. Para la American Society of Hirudotherapy, esta investigación es conceptualmente relevante porque examina el delicado manejo clínico de la anticoagulación sistémica para prevenir la trombosis sin causar hemorragia. Los compromisos fisiológicos evaluados en este estudio reflejan los efectos anticoagulantes localizados logrados por componentes del secretoma de la sanguijuela como la hirudina, aunque aplicados de forma sistémica. Sin embargo, el alcance de este estudio se limita estrictamente a evaluar el automanejo por parte del paciente de los antagonistas de la vitamina K. El resumen no contiene ninguna mención de sanguijuelas, hirudoterapia o el secretoma de la sanguijuela, lo que hace que su conexión con el campo sea puramente temática.
Citación
Impact of an oral anticoagulation self-monitoring and self-management program in patients with mechanical heart valve prosthesis.
Blanch et al. · Journal of comparative effectiveness research, 2021
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: 18 de junio de 2026